MENU
+Compare
AVIR
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$3.09
Change
-$0.05 (-1.59%)
Capitalization
260.99M

AVIR Atea Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of vaccines

Industry Biotechnology
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AVIR with price predictions
Feb 21, 2025

AVIR's Indicator enters downward trend

The Aroon Indicator for AVIR entered a downward trend on February 13, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 243 similar instances where the Aroon Indicator formed such a pattern. In of the 243 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AVIR as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AVIR moved below its 50-day moving average on January 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AVIR crossed bearishly below the 50-day moving average on January 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 47 cases where AVIR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AVIR just turned positive on February 12, 2025. Looking at past instances where AVIR's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVIR advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.569) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). AVIR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AVIR is expected to report earnings to fall 4.59% to -35 cents per share on March 04

Atea Pharmaceuticals AVIR Stock Earnings Reports
Q4'24
Est.
$-0.35
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.18
Q1'24
Missed
by $0.14
Q4'23
Missed
by $0.04
The last earnings report on November 07 showed earnings per share of -37 cents, beating the estimate of -43 cents. With 309.14K shares outstanding, the current market capitalization sits at 260.99M.
A.I. Advisor
published General Information

General Information

a developer of vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PINPX14.34-0.07
-0.49%
Principal Diversified Intl R5
MGFAX9.47-0.15
-1.56%
MassMutual Global A
GISYX17.05-0.32
-1.84%
Grandeur Peak Intl Stalwarts Instl
CMLIX47.56-1.03
-2.12%
Congress Large Cap Growth Institutional
INSIX21.68-0.55
-2.47%
Catalyst Insider Buying I

AVIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with HEPA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then HEPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-1.59%
HEPA - AVIR
47%
Loosely correlated
-9.20%
MGTX - AVIR
46%
Loosely correlated
+6.88%
AXON - AVIR
46%
Loosely correlated
-5.28%
FHTX - AVIR
45%
Loosely correlated
-2.79%
RCKT - AVIR
45%
Loosely correlated
-3.68%
More